CD274 and neoplasm: A total of 95.0% (19/20) of EBVaICCs expressed PD-L1 in tumor cells (IRS score ≥ 3), but only the 22.3% (63/283) of non-EBVaICCs case expressed PD-L1 (p < 0.0001).